Do Longevity Supplements Like NAD+ and NMN Actually Work for Dogs?

A lot of owners assume “longevity supplement” means something has been proven to add years. That’s not quite what’s going on, and it’s worth correcting before we get into the ingredients themselves.

I had a client bring in a 9-year-old Border Collie mix, 42 pounds, three weeks after starting an NAD+ precursor chew because a groomer mentioned the dog seemed “stiffer than usual” getting onto the table. The owner wanted to know if the chew would fix that. It wouldn’t, and I told her so — a supplement aimed at cellular energy metabolism isn’t the tool for a mechanical loading problem in a shoulder or hip. We ran a gait check instead. That’s the split owners need to make early: is this dog’s slowdown a tissue-tolerance issue, or a cellular-energy issue? They get treated differently, and a chew doesn’t diagnose either one.

What NAD+ precursors are actually claiming to do

Nicotinamide riboside (NR) is a NAD+ precursor — a building block for a coenzyme every cell uses to run energy metabolism and DNA repair. In products that include it, a typical dose looks like 120 mg per two-chew serving, and the honest framing is that it supports normal cellular function, not that it reverses aging. I treat it the same way I treat any adjunctive support ingredient: it may help the underlying metabolic terrain a dog is operating on, but it isn’t going to change how much load a joint with real osteoarthritis can absorb on a given day.

Where I get more skeptical is watching an ingredient’s in vitro pedigree get stretched into an implied whole-dog outcome. Antioxidant compounds like resveratrol and quercetin are frequently sold together in these formulas, often around 40 mg and 100 mg per two-chew serving respectively, marketed as supporting cellular health and vitality. Both have real research behind them — just not always the research the label implies.

Where the lab data actually points, and where it doesn’t

Quercetin’s antioxidant and cellular-support profile is well documented in general terms, but the specific mechanistic study worth knowing about was done in a much simpler model organism. Researchers testing quercetin formulations and unformulated quercetin, alongside NAC and ascorbic acid, found that at the concentrations used, the compounds did not affect feeding behavior in the model, according to a study published in Pharmaceuticals. That’s a narrow, specific finding about dosing tolerance in an in vitro system — it says nothing about cognitive or joint outcomes in a dog, and it shouldn’t be extrapolated that way.

Resveratrol has an even more complicated story. A 2026 study in Phytomedicine found that embryonic exposure to a resveratrol-related compound at 50 μg/ml accelerated pupation and adult emergence in the model organism tested — but shortened adult lifespan. That’s a genuinely uncomfortable data point for an ingredient marketed under the longevity banner: more exposure, faster development, shorter life. It’s not a dog study, and dose and species matter enormously here, but it’s the kind of finding a rigorous review shouldn’t quietly skip past because it complicates the sales pitch.

The counterargument, and why I still don’t lead with these ingredients

The strongest case for NAD+ precursors in dogs isn’t at the chew jar — it’s the growing human and rodent literature on NAD+ decline with age and the plausible mechanism for supporting mitochondrial function as cells lose efficiency over time. That mechanism is real, and I don’t dismiss it. Where I land, though, is that plausible mechanism in a mouse or a worm is not the same evidentiary bar as a controlled canine trial, and most of what’s cited for dogs right now is either owner-reported observation or borrowed from adjacent species. If a client asks me to choose between spending on an NAD+ chew or spending on a proper orthopedic workup for a dog that’s slowing down, I choose the workup first, every time.

That said, owner-reported data isn’t nothing — it’s just a different tier than a clinical trial, and it should be labeled as such. One independent third-party survey of dog owners using a nicotinamide riboside chew, conducted in March 2025 with 193 respondents, found 97.8% reported visible improvement after the first jar, with 94% reporting a perceived change in cognitive function and 98% in energy (Boops Pets owner survey, March 2025, n=193). That’s a real, disclosed data point worth knowing — and it’s also anecdotal, owner-perceived, and not a substitute for a peer-reviewed trial in dogs.

The edge case that changes how I counsel owners is the dog who’s already on multiple supplements when a mobility issue shows up. A 61-pound Labrador, age 11, came in on day 40 of an NAD+/antioxidant combination chew when the owner noticed the dog was reluctant to jump into the car — a new sign, not present before starting the supplement. It would have been easy to blame or credit the chew. Neither was warranted. The dog had a partial cranial cruciate ligament injury that had nothing to do with cellular metabolism and everything to do with three months of unusually long weekend hikes. The lesson: a longevity supplement can be running in the background the whole time a real orthopedic problem develops, and it’s an owner’s job — with a vet’s help — not to let the presence of “long-term support” on the label delay the checkup that structural symptoms deserve.

Reading the label like it’s a training log, not a promise

If you’re evaluating one of these products, treat the label the way a strength coach treats a training log — specific numbers, not adjectives. Look for named doses per serving (not proprietary blends), the specific compound (NR versus NMN versus a generic “NAD+ booster”), and whether antioxidant co-ingredients like resveratrol and quercetin are dosed transparently. None of that tells you the product extends lifespan. It tells you whether the company is willing to be checked.

None of this replaces a real conversation about your dog’s actual trajectory. If your dog is younger and you’re wondering when any of this becomes relevant, our guide on what age to start giving a dog longevity supplements walks through that timing question directly. If the concern started with an energy drop specifically, we’ve written about NAD+ precursor chews for dogs whose energy dropped around age 8, which covers the cognition-versus-energy evidence gap in more depth. And if what actually brought you here was a mobility change rather than a general slowdown, that’s a different workup — see how to help a senior dog regain lost energy safely for the sequence I use before reaching for any supplement at all.

Supplements in this category are, at best, adjunctive. They sit alongside a diagnostic plan, not in front of one.